Tenax Therapeutics (TENX)
1.94
+0.16 (8.99%)
Upcoming Events
Latest Headlines
Guggenheim Downgrades Tenax Therapeutics (TENX) to Neutral
August 31, 2026 6:09 AM - StreetInsider
Tenax shares Phase 3 LEVEL trial data at ESC Congress 2026
August 29, 2026 8:21 AM - StreetInsider
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026
August 29, 2026 8:21 AM - Globe NewsWire
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: ING GROEP NV
August 27, 2026 8:22 PM - SEC Filing
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: SPHERA FUNDS MANAGEMENT LTD.
August 27, 2026 6:20 AM - SEC Filing
Form 4 TENAX THERAPEUTICS, INC. For: Aug 20 Filed by: Schneeberger Daniel
August 24, 2026 6:13 PM - SEC Filing
Form 3 TENAX THERAPEUTICS, INC. For: Aug 20 Filed by: Schneeberger Daniel
August 24, 2026 5:51 PM - SEC Filing
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: MILLENNIUM MANAGEMENT LLC
August 18, 2026 7:09 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Ikarian Capital, LLC
August 14, 2026 9:15 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC
August 14, 2026 5:25 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Venrock Healthcare Capital Partners III, L.P.
August 14, 2026 4:58 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P
August 14, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Vivo Opportunity Fund Holdings, L.P.
August 14, 2026 4:18 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: RTW INVESTMENTS, LP
August 14, 2026 8:13 AM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P.
August 12, 2026 12:06 PM - SEC Filing
Tenax Therapeutics (TENX) PT Lowered to $4 at Guggenheim
August 11, 2026 6:45 AM - StreetInsider
Tenax Therapeutics (TENX) PT Lowered to $4 at Canaccord
August 11, 2026 6:42 AM - StreetInsider
Evercore ISI Downgrades Tenax Therapeutics (TENX) to In Line
August 10, 2026 4:17 PM - StreetInsider
William Blair Downgrades Tenax Therapeutics (TENX) to Market Perform
August 10, 2026 12:50 PM - StreetInsider
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout
August 10, 2026 8:04 AM - StreetInsider
Form 8-K TENAX THERAPEUTICS, INC. For: Aug 10
August 10, 2026 7:19 AM - SEC Filing
Tenax Therapeutics Phase 3 trial of TNX-103 misses primary endpoint
August 10, 2026 7:00 AM - StreetInsider
Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF
August 10, 2026 7:00 AM - Globe NewsWire
Tenax Therapeutics (TENX) call put ratio 1 call to 2.4 puts on 15K contracts
August 10, 2026 4:26 AM - StreetInsider
Form SCHEDULE 13D/A TENAX THERAPEUTICS, INC. Filed by: Giordano Christopher Thomas
July 31, 2026 4:16 PM - SEC Filing
Form 10-Q TENAX THERAPEUTICS, INC. For: Jun 30
July 31, 2026 11:26 AM - SEC Filing
Form 8-K TENAX THERAPEUTICS, INC. For: Jul 31
July 31, 2026 7:23 AM - SEC Filing
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
July 31, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: BlackRock, Inc.
July 30, 2026 11:19 AM - SEC Filing
Canaccord Starts Tenax Therapeutics (TENX) at Buy
July 28, 2026 7:21 AM - StreetInsider
Evercore ISI Starts Tenax Therapeutics (TENX) at Outperform
July 22, 2026 8:14 AM - StreetInsider
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: MILLENNIUM MANAGEMENT LLC
July 17, 2026 5:59 PM - SEC Filing
Form 4 TENAX THERAPEUTICS, INC. For: Jul 13 Filed by: Giordano Christopher Thomas
July 14, 2026 7:30 PM - SEC Filing
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: FMR LLC
July 8, 2026 10:12 AM - SEC Filing
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 2, 2026 4:05 PM - Globe NewsWire
Form 8-K TENAX THERAPEUTICS, INC. For: Jul 02
July 2, 2026 8:01 AM - SEC Filing
Tenax Therapeutics to present LEVEL trial data at ESC Congress
July 2, 2026 7:00 AM - StreetInsider
Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026
July 2, 2026 7:00 AM - Globe NewsWire
Form 8-K TENAX THERAPEUTICS, INC. For: Jun 29
June 30, 2026 4:31 PM - SEC Filing
Form 8-K TENAX THERAPEUTICS, INC. For: Jun 26
June 29, 2026 4:41 PM - SEC Filing
Tenax Therapeutics (TENX) Reiterated at Overweight by Cantor Fitzgerald: Ph3 Data in Q3
June 24, 2026 6:50 AM - StreetInsider
Tenax Therapeutics (TENX) PT Raised to $40 at Guggenheim
June 22, 2026 6:41 AM - StreetInsider
Chardan Starts Tenax Therapeutics (TENX) at Buy
June 22, 2026 6:10 AM - StreetInsider
Tenax Therapeutics (TENX) PT Raised at Piper Sandler: 'Here's Why Now Is The Time to Own'
June 12, 2026 7:09 AM - StreetInsider
Full Article List
